Aelis Farma is a biotech company that develops pharmaceutical therapies that target chronic and neurodegenerative diseases.
Aelis Farma has raised $528K in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Aelis Farma's investors include Bpifrance, National Institute on Drug Abuse (NIDA), Région Nouvelle-Aquitaine, Inserm Transfert Initiative, France 2030 in Nouvelle-Aquitaine.
Aelis Farma is headquartered in Bordeaux, France.
Aelis Farma is a biotech company that develops pharmaceutical therapies that target chronic and neurodegenerative diseases.
Aelis Farma is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aelis Farma — Funding & Investors." VCBacked, April 7, 2026, https://www.vcbacked.co/company/aelis-farma. Accessed July 31, 2026.
VCBacked. (2026). Aelis Farma — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/aelis-farma
{{cite web |title=Aelis Farma — Funding & Investors |url=https://www.vcbacked.co/company/aelis-farma |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated